Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Grace Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 40K | Apr 14, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GRCE | Grace Therapeutics, Inc. | Apr 14, 2025 | 1 | $0 | 4 | Apr 16, 2025 | Chief Medical Officer |
ACST | Acasti Pharma Inc. | May 6, 2024 | 1 | $0 | 4 | May 8, 2024 | Chief Medical Officer |
ACST | Acasti Pharma Inc. | Jul 14, 2023 | 1 | $0 | 4 | Jul 18, 2023 | Chief Medical Officer |
ACST | Acasti Pharma Inc. | May 8, 2023 | 0 | $0 | 3 | May 26, 2023 | Chief Medical Officer |